Immuno-Oncology
The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.
Latest News
From “Super Skeptical” Beginnings, a New Immune-Modulatory Vaccine Awaits Phase 3 Results
Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials
Early Recognition, Action Crucial for ICI-Induced Cardiovascular Adverse Effects
Dr Guru Sonpavde on the Potential of Nivolumab Plus Chemotherapy in Urothelial Carcinoma
Dr Erin Gillaspie Explains the Role of Immunotherapies in Lung Cancer Treatment
Dr Sigrun Hallmeyer: Precision Medicine Needs to Become More Efficient
Dr Jennifer Choe Discusses Head and Neck Cancer Relapse, New Treatment Trials, Promising Responses
Dr Joseph Mikhael on Strategies to Increase CAR T-Cell Therapy Access
Disparities in Germline Genetic Testing Rates Exist, but Mechanisms Remain Unclear
Dr Mark Socinski on the Importance of Targeted Therapy and Immunotherapy in NSCLC
Dr Sigrun Hallmeyer Discusses Why a Team Effort Is Vital in Precision Medicine
Dr Kevin Davies Discusses Progress Made With CRISPR
Shiela Plasencia on the Use of Social Determinants Data Collection in Oncology Care
Podcast: This Week in Managed Care—Step Therapy in Medicare Advantage and Other Health News
Addressing Financial Toxicity With Navigators and Better Conversations Around Decision Making
Podcast: This Week in Managed Care—Bringing Down Health Insurance Premiums and Other Health News
More News
The Challenge With CAR T? It’s Not the Drug, It’s the Delivery
